Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Albin

Showing results (121-130 of 242) with videos related to

Pageof 25
Sort By:
The American Journal of Pathology|January 10, 2006
Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant proteinZhigang Yu, Nahid Dadgar, Megan Albertelli, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 13, 2007
Spared caudal brainstem SERT binding in early Parkinson's diseaseRoger L Albin, Robert A Koeppe, Nicolaas I Bohnen, et al.
Annals of Neurology|April 1, 2003
Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystoniaRoger L Albin, Donna Cross, Wayne T Cornblath, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 14, 2022
Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's DiseaseKelvin L Chou, Praveen Dayalu, Robert A Koeppe, et al.
American Journal of Medical Genetics. Part A|March 5, 2015
Biallelic mutations in huntington disease: A new case with just one affected parent, review of the literature and terminologyWendy R Uhlmann, Maria S Peñaherrera, Wendy P Robinson, et al.
Neuroscience Letters|May 12, 2009
Evaluation of tetrathiomolybdate in the R6/2 model of Huntington diseaseSara J Tallaksen-Greene, Anita Janiszewska, Kasha Benton, et al.
Frontiers in Human Neuroscience|September 10, 2024
Improving efficacy of repetitive transcranial magnetic stimulation for treatment of Parkinson disease gait disordersRupsha Panda, Joseph A Deluisi, Taraz G Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2011
Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal studyNicolaas I Bohnen, Robert A Koeppe, Satoshi Minoshima, et al.
Archives of Neurology|September 12, 2012
Cerebral amyloid deposition and serotoninergic innervation in Parkinson diseaseVikas Kotagal, Nicolaas I Bohnen, Martijn L T M Müller, et al.
The Journal of Comparative Neurology|September 2, 2003
Hprt(CAG)146 mice: age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineSara J Tallaksen-Greene, Jared M Ordway, Andrew B Crouse, et al.
Pageof 25

Showing results (121-130 of 242) with videos related to

Sort By:
Pageof 25
The American Journal of Pathology|January 10, 2006
Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant proteinZhigang Yu, Nahid Dadgar, Megan Albertelli, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 13, 2007
Spared caudal brainstem SERT binding in early Parkinson's diseaseRoger L Albin, Robert A Koeppe, Nicolaas I Bohnen, et al.
Annals of Neurology|April 1, 2003
Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystoniaRoger L Albin, Donna Cross, Wayne T Cornblath, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 14, 2022
Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's DiseaseKelvin L Chou, Praveen Dayalu, Robert A Koeppe, et al.
American Journal of Medical Genetics. Part A|March 5, 2015
Biallelic mutations in huntington disease: A new case with just one affected parent, review of the literature and terminologyWendy R Uhlmann, Maria S Peñaherrera, Wendy P Robinson, et al.
Neuroscience Letters|May 12, 2009
Evaluation of tetrathiomolybdate in the R6/2 model of Huntington diseaseSara J Tallaksen-Greene, Anita Janiszewska, Kasha Benton, et al.
Frontiers in Human Neuroscience|September 10, 2024
Improving efficacy of repetitive transcranial magnetic stimulation for treatment of Parkinson disease gait disordersRupsha Panda, Joseph A Deluisi, Taraz G Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2011
Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal studyNicolaas I Bohnen, Robert A Koeppe, Satoshi Minoshima, et al.
Archives of Neurology|September 12, 2012
Cerebral amyloid deposition and serotoninergic innervation in Parkinson diseaseVikas Kotagal, Nicolaas I Bohnen, Martijn L T M Müller, et al.
The Journal of Comparative Neurology|September 2, 2003
Hprt(CAG)146 mice: age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineSara J Tallaksen-Greene, Jared M Ordway, Andrew B Crouse, et al.
Pageof 25